Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laxman Bahroo"'
Publikováno v:
Annals of Movement Disorders, Vol 2, Iss 3, Pp 83-90 (2019)
Psychosis is a common and often debilitating non-motor symptom of Parkinson’s disease (PD). It typically manifests in the form of well-formed visual hallucinations and minor hallucinations, and, at times, can present with delusions and nonvisual ha
Externí odkaz:
https://doaj.org/article/13a3ffcc310f4626914d0cfda558f6e1
Autor:
Mark F. Lew, Robert A. Hauser, Stuart H. Isaacson, Daniel Truong, Atul T. Patel, Allison Brashear, William Ondo, Pascal Maisonobe, Khashayar Dashtipour, Laxman Bahroo, Stefan Wietek
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 5, Iss , Pp 100115- (2021)
Introduction: Cervical dystonia (CD) is a neurologic movement disorder with potentially disabling effects and significant impact on quality of life of those affected. AbobotulinumtoxinA (aboBoNT-A) was initially approved for a dilution of 500 U/1 mL
Externí odkaz:
https://doaj.org/article/1b10f3346552463da42e87acfb171361
Publikováno v:
Expert review of neurotherapeutics. 22(6)
Levodopa is the most effective medication for the treatment of motor symptoms of Parkinson's disease (PD). Several factors may affect the efficacy and tolerability of levodopa. These include the timing, dosage and administration of levodopa, concomit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::530bb5937485acd55f024210f616ac5a
https://pubmed.ncbi.nlm.nih.gov/35710101
https://pubmed.ncbi.nlm.nih.gov/35710101
Publikováno v:
Annals of Movement Disorders, Vol 2, Iss 3, Pp 83-90 (2019)
Psychosis is a common and often debilitating non-motor symptom of Parkinson’s disease (PD). It typically manifests in the form of well-formed visual hallucinations and minor hallucinations, and, at times, can present with delusions and nonvisual ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f91d415afab00d2075fb18ad6e942d49
http://www.aomd.in/article.asp?issn=2590-3446
http://www.aomd.in/article.asp?issn=2590-3446
Publikováno v:
Neurodegenerative Disease Management. 8:73-80
Levodopa is the most efficacious treatment for Parkinson's disease (PD). Long-term treatment with levodopa is limited due to dyskinesia. Dyskinesia in PD can be socially and functionally disabling. Extended-release amantadine (amantadine ER) is the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddd10f0236556ae157f76368f391203c
https://doi.org/10.2217/nmt-2018-0001
https://doi.org/10.2217/nmt-2018-0001
Autor:
Mazen T. Elkurd, Laxman Bahroo
Publikováno v:
CNS spectrums. 24(S1)
Tardive dyskinesia (TD) was first described in 1964, but treatment for this sometimes poorly characterized condition lagged decades as it was labored by medico-legal implications. TD has often been lumped with other medication-induced disorders and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b666fdbaa596841311d27e403c06e1e
https://pubmed.ncbi.nlm.nih.gov/31482777
https://pubmed.ncbi.nlm.nih.gov/31482777